<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="were made. 12th European Headache Federation Congress EHF 2018 Florence," exact="Italy" post="28-30 September 2018 EHF Invited Speakers S1 KATP channels"/>
 <result pre="Neurology, Faculty of Health and Medical Sciences, University of Copenhagen," exact="Denmark" post="This abstract was not included as it has been"/>
 <result pre="Lampl (Christian.Lampl@ordensklinikum.at) Headache Medical Center, Seilerstätte, Ordensklinikum Linz Barmherzige Schwestern," exact="Austria" post="Background According to the new ICHD 3 diagnostic criteria"/>
 <result pre="Sciences and Biotechnology, Section of Neurology, University of L’Aquila, L’Aquila," exact="Italy" post="The role of female hormones in the pathogenesis of"/>
 <result pre="Sciences and Biotechnology, Section of Neurology, University of L’Aquila, L’Aquila," exact="Italy" post="Great enthusiasm is preceding the marketing of new treatments"/>
 <result pre="Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva," exact="Israel" post="Although extremely common, Post Traumatic Headache (PTH) deserves little"/>
 <result pre="Burstein Department of Anesthesia, Critical Care and Pain Medicine, Beth" exact="Israel" post="Deaconess Medical Center, Harvard Medical School, Boston, MA Correspondence:"/>
 <result pre="Padova, 35121 Padova, Italy; 2CNR Institute of Neuroscience, 35121 Padova," exact="Italy" post="Migraine is much more than an episodic headache disorder."/>
 <result pre="Headache Center, Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen," exact="Denmark" post="In 1968, the first study linking prostaglandins and migraine"/>
 <result pre="Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen," exact="Denmark" post="Pituitary adenylate cyclase-activating peptide-38 (PACAP38), a vasoactive signaling molecule"/>
 <result pre="J. Steiner (t.steiner@imperial.ac.uk) Norwegian University of Science and Technology, Trondheim," exact="Norway" post="Headache disorders are now recognized as the second cause"/>
 <result pre="(dmagis@chuliege.be) Headache Research Unit, University Department of Neurology CHR, Liège," exact="Belgium" post="Increased responsivity to environmental stimuli is associated with migraine"/>
 <result pre="(amelo1@bidmc.harvard.edu) Department of Anesthesia, Critical Care and Pain Medicine. Beth" exact="Israel" post="Deaconess Medical Center. Harvard Medical School, Boston, MA, USA"/>
 <result pre="headache Rami Burstein Department of Anesthesia and Critical Care, Beth" exact="Israel" post="Deaconess Medical Center Cortical spreading depression (CSD) has long"/>
 <result pre="from randomized controlled trials. Three health-care systems – of Russia," exact="Spain" post="and Luxemburg – brought different experiences of health service"/>
 <result pre="the greater are the economic savings for society (Luxemburg &amp;gt;" exact="Spain" post="&amp;gt; Russia). Discussion: For the first time, the effectiveness"/>
 <result pre="Schytz (henrikschytz@hotmail.com) Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup," exact="Denmark" post="Secondary headaches are often a huge challenge to clinicians"/>
 <result pre="Rigshospitalet and Institute for Neuroscience, University of Copenhagen, Glostrup, DK-2600," exact="Denmark" post="Cortical spreading depression and depolarization waves (CSD) are associated"/>
 <result pre="Burstein Department of Anesthesia, Critical Care &amp;amp; Pain Medicine, Beth" exact="Israel" post="Deaconess Medical Center, Harvard Medical School, Boston MA, USA"/>
 <result pre="Neurophysiology, St. Olavs hospital HF, Trondheim University Hospital, 7006, Trondheim," exact="Norway" post="Obligatory and common symptoms like phonophobia, photophobia and allodynia"/>
 <result pre="in fully blinded visual evoked potential (VEP) studies, neither in" exact="Norway" post="nor in the Netherlands. It is of course very"/>
 <result pre="Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan," exact="Italy" post="Correspondence: Roberta Messina (messina.roberta@hsr.it) Over the last two decades,"/>
 <result pre="Hospital, Rome, Italy; 6Regional Referral Headache Center, Sant’Andrea Hospital, Rome," exact="Italy" post="Correspondence: Paolo Martelletti (paolo.martelletti@uniroma1.it) The evidence of multiple comorbidities"/>
 <result pre="- Narilis University of Namur, Belgium; 4European Headache Federation, Rome," exact="Italy" post="Correspondence: Efstratia Vatzaki (Efstratia.Vatzaki@ema.europa.eu) Migraine is a common and"/>
 <result pre="of Montpellier, and Headache Centre, Neurology department, Montpellier University Hospital," exact="France" post="According to ICHD-3, migraine with brainstem aura is defined"/>
 <result pre="does exist Jes Olesen (jes.olesen@regionh.dk) Rigshospitalet and university of Copenhagen," exact="Denmark" post="Migraine with brainstem aura has been a recognized entity"/>
 <result pre="Rehabilitación y Medicina Física. Universidad Rey Juan Carlos, Alcorcón, Madrid," exact="Spain" post="The etiology of tension type headache (TTH) is not"/>
 <result pre="Center &amp;amp; Dept. of Neurology, Righospitalet Glostrup, University of Copenhagen," exact="Denmark" post="Neuroimaging studies have substantially enhanced our possibilities for investigating"/>
 <result pre="Neuroscience, Department of Human Neuroscience, &quot;Sapienza&quot; University of Rome, Rome," exact="Italy" post="Correspondence: V. Guidetti (vincenzo.guidetti@uniroma1.it) In 1942 Conrad Waddington defined"/>
 <result pre="Movement Science, NTNU Norwegian University of Science and Technology, Trondheim," exact="Norway" post="According to the new version of the International Classification"/>
 <result pre="of Science and Technology (NTNU), and St. Olavs Hospital, Trondheim," exact="Norway" post="For a small country, Norway has made substantial contributions"/>
 <result pre="and St. Olavs Hospital, Trondheim, Norway For a small country," exact="Norway" post="has made substantial contributions to the headache field. The"/>
 <result pre="Neurology, Catholic University, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome," exact="Italy" post="Background Migraine is a pleomorphic relapsing, remitting disorders characterized"/>
 <result pre="and headache Lidia Savi (lsavi@cittadellasalute.to.it) Headache Center LBS, Lugano, 6900," exact="Switzerland" post="Headache disorders are in many cases inadequately managed with"/>
 <result pre="Guidelines of Scientific Societies from different countries (USA, Italy, England," exact="Switzerland" post=", etc) consider these products with sometimes conflicting information."/>
 <result pre="8FI.CEF Onlus, Italian Headache Foundation, via Celoria 11, 20133 Milan," exact="Italy" post="Correspondence: Paola Brusa (paola.brusa@unito.it) Background. A study was carried"/>
 <result pre="Paola Brusa (paola.brusa@unito.it) Background. A study was carried out in" exact="Italy" post="with the objective of analysing the patterns of use"/>
 <result pre="Community pharmacies as epidemiological sentinels of headache: first experience in" exact="Italy" post="Neurol Sci 2017; 38(Suppl 1): 15-20. 2. Lipton RB,"/>
 <result pre="Department of Mechanical Energy Management Engineering, University of Calabria Rende" exact="Italy" post="Correspondence: Rosario Iannacchero (centrocefaleeaopc@gmail.com) Introduction: Good clinical governance of"/>
 <result pre="2Clinica del Mal di Testa, via campania 37, Roma, 00161," exact="Italy" post="Headaches are one of the most disabling disorders [1]."/>
 <result pre="Società Italiana per lo Studio delle Cefalee - Sezione Lombardia," exact="Italy" post="1UO Neurologia - Centro Cefalee, Humanitas Gavazzeni, Bergamo; 2Centro"/>
 <result pre="Rome Polo Pontino, Department of Medico-Surgical Sciences and Biotechnologies, Latina," exact="Italy" post="Presently, migraine is considered a brain disorder. Many independent"/>
 <result pre="Cherubino Di Lorenzo (cherub@inwind.it) IRCCS Fondazione Don Carlo Gnocchi, Milan," exact="Italy" post="Background. The most of migraineurs patients referred to a"/>
 <result pre="Cherubino Di Lorenzo (cherub@inwind.it) IRCCS Fondazione Don Carlo Gnocchi, Milan," exact="Italy" post="Background. Although migraine is a neurological disorder in which"/>
 <result pre="and Neurophthalmology, Rome, Italy; 3IRCCS Fondazione Don Carlo Gnocchi, Milan," exact="Italy" post="Correspondence: Francesco Pierelli; Cherubino Di Lorenzo (cherub@inwind.it) Background. Ketogenic"/>
 <result pre="Headache Centre, Neurological Division, SS Giovanni e Paolo Hospital, Venice," exact="Italy" post="As in the previous version, chapter 10 of the"/>
 <result pre="Headache Centre, Department of Neurology, Azienda Sanitaria Friuli Occidentale, Pordenone," exact="Italy" post="Headache and sleep disturbances represent some of the most"/>
 <result pre="Rehabilitación y Medicina Física, Universidad Rey Juan Carlos, Alcorcón, Madrid," exact="Spain" post="Headache is the medical problem most commonly observed by"/>
 <result pre="Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari," exact="Italy" post="Most of the studies concerning psychiatric comorbidity in migraine"/>
 <result pre="(dl.hay@auckland.ac.nz) School of Biological Sciences, The University of Auckland, Auckland," exact="New Zealand" post="There is high interest in blocking the actions of"/>
 <result pre="Germany; 3Department of Clinical Biochemistry, Bispebjerg Hospital, University of Copenhagen," exact="Denmark" post="; 4Department of Clinical Biochemistry, Rigshospitalet Glostrup, Denmark ;"/>
 <result pre="of Copenhagen, Denmark ; 4Department of Clinical Biochemistry, Rigshospitalet Glostrup," exact="Denmark" post="; 5OPEN, Odense Patient Data Explorative Network, Odense University"/>
 <result pre="University Hospital/Institute of Clinical Research, University of Southern Denmark, Odense," exact="Denmark" post="; 6Section of Biostatistics, University of Copenhagen, Denmark Correspondence:"/>
 <result pre="Denmark, Odense, Denmark ; 6Section of Biostatistics, University of Copenhagen," exact="Denmark" post="Correspondence: Messoud Ashina (ashina@dadlnet.dk) &amp;amp; The first two authors"/>
 <result pre="2Department of Brain and Behavioural Sciences, University of Pavia, Pavia," exact="Italy" post="Correspondence: Michele Viana (michele.viana@ymail.com) Introduction: Factors implicated in the"/>
 <result pre="Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth" exact="Israel" post="Deaconess Medical Center, Boston, MA, USA; 2Department of Radiology,"/>
 <result pre="Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen," exact="Denmark" post="Correspondence: Sabrina Khan (sksabrinakhan@gmail.com) The origin of migraine pain"/>
 <result pre="Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen," exact="Denmark" post="Correspondence: Messoud Ashina (ashina@dadlnet.dk) &amp;amp; These authors contributed equally"/>
 <result pre="approved by the Ethics Committee of the Capital Region of" exact="Denmark" post="(H-16014580) and is registered at ClinicalTrials.gov (NCT03481400). All participants"/>
 <result pre="Bergmannstrost, Halle/ Saale, Germany; 6Department of Neurology, Ludwig-Maximilians-University Munich, Munich-Grosshadern," exact="Germany" post="Correspondence: Thomas Dresler (thomas.dresler@med.uni-tuebingen.de) Background: Post stroke headache (symptomatic"/>
 <result pre="Center, Department of Neurology, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, 2600," exact="Denmark" post="Correspondence: Elena R. Lebedeva (elenalebedeva1971@gmail.com) Background: Headache is a"/>
 <result pre="Health, AOU Città della Salute e della Scienza di Torino," exact="Italy" post="Correpondence: Elisa Rubino (elisa.rubino@unito.it) Background. Migraine is a common"/>
 <result pre="University Hospital, Lørenskog; 6Department of Neurology, Akershus University Hospital, Lørenskog," exact="Norway" post="Correspondence: Espen Saxhaug Kristoffersen (e.s.kristoffersen@medisin.uio.no) Introduction Data on the"/>
 <result pre="Neurophysiology of Vision and Neurophthalmology, Rome, Italy; 4IRCCS-Neuromed, Pozzilli (IS)," exact="Italy" post="Correspondence: Gianluca Coppola (gianluca.coppola@gmail.com) Background Injection botulinum toxin type"/>
 <result pre="a wide-reaching group of clinicians reflecting practice from across the" exact="United Kingdom" post="and internationally. The statements were then critically reviewed key"/>
 <result pre="2Emergency Headache Centre &amp;amp; 4Neurology Department, Lariboisière Hospital, APHP, Paris," exact="France" post="Correspondence: Rosalie Boitet (rosalie.boitet@gmail.com) Introduction: Long-term outcomes &amp;gt;5 years"/>
 <result pre="Engelstoft, Lars Bendtsen Danish Headache Center, Neurological Clinic, Rigshospitalet, Glostrup," exact="Denmark" post="Correspondence: Louise N. Carlsen (louise.ninett.carlsen@regionh.dk) Background: Complete stop of"/>
 <result pre="The study was approved by the Regional Ethical Committee in" exact="Denmark" post="(H-1-2012- 105 116) O24 The economic and humanistic burden"/>
 <result pre="and utility outcomes (published 2007– February 1, 2018; geographical limitation:" exact="United Kingdom," post="France, Germany, Spain, Italy, the Netherlands, Poland, Denmark, Finland,"/>
 <result pre="France, Germany, Spain, Italy, the Netherlands, Poland, Denmark, Finland, Iceland," exact="Norway" post="and Sweden). Searches included: Embase, MEDLINE, and the Cochrane"/>
 <result pre="of Applied Clinical Science and Biotechnology, University of L’Aquila, L’Aquila," exact="Italy" post="Correspondence: Francesca Pistoia (francesca.pistoia@univaq.it) Background Allodynia is a phenomenon"/>
 <result pre="Italy; 3Interinstitutional Multidisciplinary Biobank (BioBIM), IRCCS San Raffaele Pisana, Rome," exact="Italy" post="Correpondence: P. Barbanti (piero.barbanti@sanraffaele.it) Background: Dopamine (DA) plays a"/>
 <result pre="12Neurophysiology and Pain Unit, University of Bari Aldo Moro, Bari," exact="Italy" post="Correspondence: Paolo Martelletti (paolo.martelletti@uniroma1.it) Background: The randomised sham-controlled PRESTO"/>
 <result pre="University Hospitals Birmingham NHS Trust, Queen Elizabeth Hospital Birmingham, Birmingham," exact="United Kingdom;" post="2Roche Products Ltd., Welwyn Garden City, United Kingdom; 3Genentech,"/>
 <result pre="Birmingham, Birmingham, United Kingdom; 2Roche Products Ltd., Welwyn Garden City," exact="United Kingdom;" post="3Genentech, South San Francisco, California; 4Massachusetts General Hospital Rheumatology"/>
 <result pre="4Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, Massachusetts," exact="United States" post="Correspondence: Susan P. Mollan (susan.mollan@uhb.nhs.uk) Introduction: The efficacy and"/>
 <result pre="Lariboisière Hospital, APHP, Paris, France; 10Rheumatology, Mount Sinai Hospital, Toronto," exact="Canada" post="Correspondence: Anne Ducros (a-ducros@chu-montpellier.fr) Distinguishing primary angiitis of the"/>
 <result pre="12Department of Brain and Behavioral Sciences, University of Pavia, Pavia," exact="Italy" post="Correspondence: Simona Sacco (simona.sacco@univaq.it) Background Chronic migraine (CM) is"/>
 <result pre="This project was supported by an unconditional grant from Allergan" exact="Italy" post="to the Fondazione Italiana per lo Studio delle Cefalee"/>
 <result pre="Jensen, Lars Bendtsen Danish Headache Center, Neurological Clinic, Rigshospitalet, Glostrup," exact="Denmark" post="Correspondence: Louise N. Carlsen (louise.ninett.carlsen@regionh.dk) Background: Complete stop of"/>
 <result pre="The study was approved by the Regional Ethical Committee in" exact="Denmark" post="(H-1-2012- 105 116) O38 Impact of fremanezumab on response"/>
 <result pre="USA; 3Teva Pharmaceuticals, Frazer, Pennsylvania, USA; 4Teva Pharmaceuticals, Buenos Aires," exact="Argentina" post="Correspondence: Paul K. Winner (khokenson@hcg-int.com) BACKGROUND: Preventive medication is"/>
 <result pre="USA; 3Teva Pharmaceuticals, Frazer, Pennsylvania, USA; 4Teva Pharmaceuticals, Buenos Aires," exact="Argentina" post="BACKGROUND: Fremanezumab, a fully humanized monoclonal antibody (IgG2a) that"/>
 <result pre="USA; 3Teva Pharmaceuticals, Frazer, Pennsylvania, USA; 4Teva Pharmaceuticals, Buenos Aires," exact="Argentina" post="Correspondence: Peter McAllister (jpotuzak@hcg-int.com) BACKGROUND: Fremanezumab, a fully humanized"/>
 <result pre="Medicine, Dept. of Neurophysiology, Rigshospitalet – Glostrup, University of Copenhagen," exact="Denmark" post="Correspondence: Nunu Lund (nunu.lund@regionh.dk) Background and aim: Cluster headache"/>
 <result pre="approved by the ethics committee of the Capital Region of" exact="Denmark" post="(H-7-2014-020) and the protocol was published at clinical trials.gov"/>
 <result pre="6Headache Research Group. Vall d’Hebron Institut de Recerca (VHIR), Barcelona," exact="Spain" post="Correspondence: D. García-Azorin (davilink@hotmail.com) Background: In migraine, the therapeutic"/>
 <result pre="was to evaluate real-life clinical prescribing practice amongst neurologists in" exact="Spain" post="Methods: Observational descriptive study done with a survey by"/>
 <result pre="Denmark; 2Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Gentofte," exact="Denmark" post="Correspondence: Messoud Ashina (ashina@dadlnet.dk) Objective To investigate the effect"/>
 <result pre="of Medical and Surgical Sciences, Magna Græcia University of Catanzaro," exact="Italy" post="; 5Neuroimaging Research Unit, Institute of Bioimaging and Molecular"/>
 <result pre="Institute of Bioimaging and Molecular Physiology, National Research Council, Catanzaro," exact="Italy" post="Correspondence: G. Demonte (g.dem.1990@gmail.com) Background It is needed to"/>
 <result pre="USA; 12Headache and Pain Unit, IRCCS San Raffaele Pisana, Rome," exact="Italy" post="Correspondence: Licia Grazzi (licia.grazzi@istituto-besta.it) Background: The multicentre, double-blind, randomised,"/>
 <result pre="Ferrara, Italy, 3Headache Centre, Department of Neurology, Piove di Sacco," exact="Italy" post="4Headache Centre, Department of Neurosciences, Padua, Italy Correspondence: C."/>
 <result pre="Piove di Sacco, Italy 4Headache Centre, Department of Neurosciences, Padua," exact="Italy" post="Correspondence: C. Lisotto (carlo.lisotto@aas5.sanita.fvg.it) Objectives Sarcoidosis is a multi-organ"/>
 <result pre="an observational study Lidia Savi (lsavi@cittadellasalute.to.it) Headache Center LBS, Lugano," exact="Switzerland" post="BACKGROUND: A new phytotherapic combination of Tanacethum Parthenium (150"/>
 <result pre="Alberto Polo Neurology department- Mater Salutis Hospital- ULSS Scaligera, Verona," exact="Italy" post="Correspondence: Silvia Ricci (silv.ricci@yahoo.it) Background It is widely accepted"/>
 <result pre="Consortium for Adaptive Disorders and Head pain – UCADH, Pavia," exact="Italy" post="Correspondence: Alessandro Viganò (alessandro.vigano@uniroma1.it) Background: Therapeutic management of Chronic"/>
 <result pre="3 Istituto Europeo di Psicoterapia Psicoanalitica (IREP), 00187 - Rome," exact="Italy" post="Correspondence: B. Petolicchio (barbara.petolicchio@uniroma1.it) Background The preventive treatment for"/>
 <result pre="of Medico-Surgical Sciences and Biotechnologies, Latina, Italy; 5IRCCS-Neuromed, Pozzilli (IS)," exact="Italy" post="Correspondence: Gianluca Coppola (gianluca.coppola@gmail.com) Background The functional connectivity (FC)"/>
 <result pre="Tarantino, Massimiliano Valeriani Headache Center Bambino Gesù Children Hospital, Rome" exact="Italy" post="Correspondence: Laura Papetti (laura.papetti@opbg.net) Introduction Primary new daily persistent"/>
 <result pre="Metabolic and Ageing Sciences, University of Campania &quot;Luigi Vanvitelli&quot;, Naples," exact="Italy" post="Correspondence: Lanfranco Pellesi (lanfranco.pellesi@gmail.com) Background Nummular headache, also known"/>
 <result pre="Professor of Neurology, National and Kapodistrian University of Athens, Athens," exact="Greece" post="Correspondence: Maria Kalogeropoulou (maria.kalogeropoulou@novartis.com) Background: Migraine is a common"/>
 <result pre="tests. The results of a national survey of migraineurs in" exact="Greece" post="reporting days absent from work (absenteeism) and days with"/>
 <result pre="the total direct cost for the management of migraine in" exact="Greece" post="is €301,969,046. The total indirect costs due to lost"/>
 <result pre="represent out-of-pocket expenses. Consequently, the economic burden of migraine in" exact="Greece" post="for the year 2017 (including both direct and indirect"/>
 <result pre="about €447,054,179. Conclusion: The total economic burden of migraine in" exact="Greece" post="has been estimated at about half billion euros for"/>
 <result pre="1Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; 2Beth" exact="Israel" post="Deaconess Medical Center Comprehensive Headache Center, Harvard Medical School,"/>
 <result pre="Ribbe 8, Pamela Vo 8 1Neurology Arizona, Mayo Clinic, Phoenix," exact="United States;" post="2GFK, Madrid, Spain; 3GfK Health, Basel, Switzerland; 4Department of"/>
 <result pre="Switzerland; 9European Headache Alliance, Brussels, Belgium; 10Migraine Association Ireland, Dublin," exact="Ireland" post="11Rigshospitalet Glostrup, Copenhagen, Denmark; 12European Federation of Neurological Associations,"/>
 <result pre="12European Federation of Neurological Associations, Brussels, Belgium; 13Migraine Action, Leicester," exact="United Kingdom;" post="14Migraine Again, United States Correspondence: Todd J. Schwedt (Schwedt.Todd@mayo.edu)"/>
 <result pre="Associations, Brussels, Belgium; 13Migraine Action, Leicester, United Kingdom; 14Migraine Again," exact="United States" post="Correspondence: Todd J. Schwedt (Schwedt.Todd@mayo.edu) Objectives Migraine-induced disability results"/>
 <result pre="Funding This study was funded by Novartis Pharma AG, Basel," exact="Switzerland" post="References 1. Steiner TJ, Stovner LJ, Vos T, Jensen"/>
 <result pre="and Health Sciences, Norwegian University of Science and Technology, Trondheim," exact="Norway" post="Correspondence: Lena H. Nordhaug (lena.h.nordhaug@ntnu.no) Background Headache is the"/>
 <result pre="Clinic Königstein, Königstein im Taunus, Germany; 6Novartis Pharma AG, Basel," exact="Switzerland" post="Correspondence: Paolo Martelletti (paolo.martelletti@uniroma1.it) Background Migraine is the most"/>
 <result pre="months in 167 headache clinics across 17 European countries and" exact="Israel" post="in adult migraine patients (aged 18–65 years) who have"/>
 <result pre="of Rome, Rome, Italy; 5EHF; 6Neurology Arizona, Mayo Clinic, Phoenix," exact="United States;" post="7Département d’Evaluation et Traitement de la Douleur, Centre Hospitalo-Universitaire"/>
 <result pre="Brussels, Belgium; 12Migraine Association Ireland, Dublin, Ireland; 13Migraine Action, Leicester," exact="United Kingdom;" post="14Migraine Again, United States Correspondence: Elena Ruiz de la"/>
 <result pre="Ireland, Dublin, Ireland; 13Migraine Action, Leicester, United Kingdom; 14Migraine Again," exact="United States" post="Correspondence: Elena Ruiz de la Torre (elena@europeanheadachealliance.org) Introduction The"/>
 <result pre="Funding This study was funded by Novartis Pharma AG, Basel" exact="Switzerland" post="P18 Economic burden of migraine: healthcare resource utilization in"/>
 <result pre="Spain; 4GfK Health, Basel, Switzerland; 5Neurology Arizona, Mayo Clinic, Phoenix," exact="United States;" post="6Département d’Evaluation et Traitement de la Douleur, Centre Hospitalo-Universitaire"/>
 <result pre="and Headache Center, University Duisburg-Essen, Germany; 8Novartis Pharma AG, Basel," exact="Switzerland" post="9European Headache Alliance, Brussels, Belgium; 10Migraine Association Ireland, Dublin,"/>
 <result pre="Brussels, Belgium; 10Migraine Association Ireland, Dublin, Ireland; 11Migraine Action, Leicester," exact="United Kingdom;" post="12European Federation of Neurological Associations, Brussels, Belgium; 13Rigshospitalet Glostrup,"/>
 <result pre="Neurological Associations, Brussels, Belgium; 13Rigshospitalet Glostrup, Copenhagen, Denmark; 14Migraine Again," exact="United States" post="Correspondence: Paolo Martelletti (paolo.martelletti@uniroma1.it) Introduction Migraine is a distinct"/>
 <result pre="Funding This study was funded by Novartis Pharma AG, Basel," exact="Switzerland" post="Table 1 (abstract P18). Resource utilization in previous 12"/>
 <result pre="6Amgen Inc., Thousand Oaks, CA, USA; 7Novartis Pharma AG., Basel," exact="Switzerland" post="Correspondence: Peter J. Goadsby (peter.goadsby@kcl.ac.uk) Background To assess efficacy"/>
 <result pre="Pharmaceuticals Corporation, East Hanover, NJ, USA; 7Novartis Pharma AG, Basel," exact="Switzerland" post="Correspondence: Uwe Reuter (Uwe.Reuter@charite.de) Background Erenumab is a fully"/>
 <result pre="human anti-calcitonin gene-related peptide receptor antibody recently approved in the" exact="United States" post="and recommended for approval in Europe as a preventive"/>
 <result pre="D Mikol 3 1Prague Headache Center, DADO MEDICAL s.r.o., Prague," exact="Czech Republic;" post="2Novartis Pharma AG, Basel, Switzerland; 3Amgen Inc., Thousand Oaks,"/>
 <result pre="6Amgen Inc., Thousand Oaks, CA, USA; 7Novartis Pharma AG, Basel," exact="Switzerland" post="Correspondence: Messoud Ashina (ashina@dadlnet.dk) Background: To assess long-term safety"/>
 <result pre="Nashville, TN, USA; 5DADO MEDICAL sro, Prague Headache Center, Prague," exact="Czech Republic;" post="6Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA;"/>
 <result pre="of Vision and Neurophthalmology, Rome, Italy; 4IRCCS Neuromed, Pozzilli (IS)," exact="Italy" post="Correspondence: Gianluca Coppola (gianluca.coppola@gmail.com) Background In healthy controls (HCs),"/>
 <result pre="Dept. of Internal Medicine, Erasmus University Medical Center, Rotterdam, The" exact="Netherlands" post="Correspondence: Eloísa Rubio-Beltran (a.rubiobeltran@erasmusmc.nl) Propranolol is a β-adrenoceptor antagonist"/>
 <result pre="Serbia, Belgrade, Serbia; 4Department of Neurology, Maastad Hospital, Rotterdam, The" exact="Netherlands" post="5Department of Neurology, Elsabeth-Tweesteden Hospital, Tilburg, The Netherlands 6Center"/>
 <result pre="Rotterdam, The Netherlands 5Department of Neurology, Elsabeth-Tweesteden Hospital, Tilburg, The" exact="Netherlands" post="6Center of Neurology, Asklepios Hospitals Schildautal, Seesen, Germany; 7Department"/>
 <result pre="Germany; 7Department of Neurology, university Hospital Essen, University of Duisburg-Essen," exact="Germany" post="Correspondence: Jeppe Hvedstrup (jeppe.hvedstrup.mann@regionh.dk) Background: Intracranial pressure (ICP) is"/>
 <result pre="Centre, San Vito al Tagliamento hospital, San Vito al Tagliamento," exact="Italy" post="Correspondence: Federico Mainardi (fmainardi@iol.it) Introduction: Post-dural puncture headache (PDH)"/>
 <result pre="3Mathematics Institute of Orsay, Paris Sud University, CNRS, 91405 Orsay," exact="France" post="Correspondence: Manjit Matharu (m.matharu@uclmail.net) Background: Very few cases of"/>
 <result pre="Turkey; 4Düzce University School of Medicine, Professor, Biostatistics Department, Düzce," exact="Turkey" post="Correspondence: Osman Özgür Yalın (osmanozguryalin@yahoo.com) Background: Migraine is a"/>
 <result pre="Isabel Luzeiro Neurology Department, Coimbra University and Hospital Centre, Coimbra," exact="Portugal" post="Correspondence: Ana-Inês Martins (ana.inesm@hotmail.com) Background: Chronic migraine (CM) is"/>
 <result pre="Clínicas, Instituto de Investigación Sanitaria (IDIS). Santiago de Compostela, 15706," exact="Spain" post="Correspondence: C. Dominguez (claravivero@hotmail.com) Background: White matter lessions (WML)"/>
 <result pre="Clínicas, Instituto de Investigación Sanitaria (IDIS). Santiago de Compostela, 15706," exact="Spain" post="Correspondence: C. Dominguez (claravivero@hotmail.com) Background: Response to treatment with"/>
 <result pre="Montreal, QC, Canada; 6Prague Headache Center, DADO MEDICAL s.r.o., Prague," exact="Czech Republic;" post="7Novartis Pharma AG, Basel, Switzerland; 8Amgen Inc., Thousand Oaks,"/>
 <result pre="University, Budapest, Hungary; 3Department of Neurology, Vaszary Kolos Hospital, Esztergom," exact="Hungary" post="Correspondence: C. Ertsey (konfreg1@bcdtravel.hu) Introduction: Validated migraine screening tools"/>
 <result pre="Faculty of Medicine, Department of Biostatistics and Medical Informatics, Mersin," exact="Turkey" post="Correspondence: P. Yalınay Dikmen (pinar.yalinay@acibadem.com) Background: The Headache Impact"/>
 <result pre="migraine. Methods: Migraine patients applying to three Neurology Clinics in" exact="Turkey" post="were evaluated at the baseline (visit 1) and week"/>
 <result pre="of Medical and Surgical Sciences, Magna Graecia University of Catanzaro," exact="Italy" post="Correspondence: L. Rapisarda (laura_rapisarda90@yahoo.it) Background It is well recognized"/>
 <result pre="Modena and Reggio Emilia, Via del Pozzo 71, 41124, Modena," exact="Italy" post="Correspondence: Baraldi Carlo (Carloinfocarlo.baraldi@gmail.com) Background Disorientation, nausea, imbalance, confusion,"/>
 <result pre="and Neurological Diseases Training and Research Hospital, Neurology Department, Istanbul," exact="Turkey" post="Correspondence: Füsun Mayda Domaç (fusundomac@yahoo.com.tr) OBJECTIVE:Headaches associated with physical"/>
 <result pre="Albania; 2Neurology, Faculty of Medicine, University of Medicine, Tirana, 1000," exact="Albania" post="Correspondence: A.Quka (aidaquka@gmail.com) Introduction: Headache remains an important symptom"/>
 <result pre="child neurology, Kharkiv Medical Academy of Postgraduate Education, Kharkiv, 61176," exact="Ukraine" post="Background. The Worldwide prevalence of tension-type headache (TTH) an"/>
 <result pre="tension-type headache (TTH) an average of 42% in adults. In" exact="Ukraine" post="the prevalence of TTH in adolescents is poor documented."/>
 <result pre="Turkey; 4Health Sciences University, Istanbul Training and Research Hospital, İstanbul," exact="Turkey" post="Correspondence: Osman Özgür Yalın (osmanozguryalin@yahoo.com) Objective: We aimed to"/>
 <result pre="Turkey; 10Düzce University School of Medicine, Professor, Biostatistics Department, Düzce," exact="Turkey" post="Correspondence: Osman Özgür Yalın (osmanozguryalin@yahoo.com) Introduction: Cerebral Venous Sinus"/>
 <result pre="Turkey; 11Düzce University School of Medicine, Professor, Biostatistics Department, Düzce," exact="Turkey" post="Correspondence: Osman Özgür Yalın (osmanozguryalin@yahoo.com) Background: Chronic migraine is"/>
 <result pre="Clinical School, Sydney Medical School, University of Sydney, Camperdown, 2006," exact="Australia" post="Correspondence: Zeljka Calic (zcalic@hotmail.com) Background Migraine is considered the"/>
 <result pre="3Unit of Epidemiology, Regional Health Service, ASL TO3, Grugliasco (TO)," exact="Italy" post="Correspondence: Antonia Versace (aversace@cittadellasalute.to.it) Objective: to investigate the connection"/>
 <result pre="and P. Luccarini* Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand," exact="France" post="Correspondence: M. Megemont (philippe.luccarini@uca.fr) Repeated migraine attacks are associated"/>
 <result pre="of Children’s Health of the Ministry of Health of the" exact="Russian Federation," post="Moscow, 119991, Russian Federation Correspondence: Vladlena Shevchenkoˡ (vladashevchenko@list.ru) Background:"/>
 <result pre="the Ministry of Health of the Russian Federation, Moscow, 119991," exact="Russian Federation" post="Correspondence: Vladlena Shevchenkoˡ (vladashevchenko@list.ru) Background: Chronic migraine (CM) is"/>
 <result pre="of Rome, Rome, Italy; 5EHF; 6Neurology Arizona, Mayo Clinic, Phoenix," exact="United States;" post="7Department of Neurology and Headache Center, University Duisburg-Essen, Germany;"/>
 <result pre="Brussels, Belgium; 10Migraine Association Ireland, Dublin, Ireland; 11Migraine Action, Leicester," exact="United Kingdom;" post="12European Federation of Neurological Associations, Brussels, Belgium; 13Rigshospitalet Glostrup,"/>
 <result pre="Neurological Associations, Brussels, Belgium; 13Rigshospitalet Glostrup, Copenhagen, Denmark; 14Migraine Again," exact="United States" post="Correspondence: Michel Lanteri-Minet (lanteri-minet.m@chu-nice.fr) Introduction Limited evidence exists on"/>
 <result pre="Funding This study was funded by Novartis Pharma AG, Basel" exact="Switzerland" post="Table 1 (abstract P65). Description of the migraine phases"/>
 <result pre="Sciences, University of Copenhagen, Valdemar Hansens vej 5, DK-2600 Glostrup," exact="Denmark" post="Correspondence: Messoud Ashina (ashina@dadlnet.dk) This abstract was not included"/>
 <result pre="Son Espases, Carretera de Valldemossa, 79. 07120, Palma, Illes Balears," exact="Spain" post="Correspondence: Javier Camiña Muñiz (javier.camina.muniz@gmail.com) Background: Trigeminal neuralgia is"/>
 <result pre="Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona," exact="Spain" post="Correspondence: P.Pozo-Rosich (ppozorosich@yahoo.com) Objective: To analyze the clinical characteristics"/>
 <result pre="Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Leuven University," exact="Belgium" post="Correspondence: Sarah Mingels (sarah.mingels@uhasselt.be) Background The International Classification of"/>
 <result pre="Neurosurgery. Hospital de la Santa Creu i Sant Pau. Barcelona." exact="Spain" post="Correspondence: Robert Belvís (rbelvis@santpau.cat) Several surgical procedures have been"/>
 <result pre="of Ophthalmology, Leiden University Medical Center, Leiden, 2300 WB, The" exact="Netherlands" post="Correspondence: Irene de Boer (ideboer@lumc.nl) Background Retinal Vasculopathy with"/>
 <result pre="Italy; 2Department of Brain and Behavioral Sciences, University of Pavia," exact="Italy" post="Correspondence: Bottiroli Sara (sara.bottiroli@mondino.it) Objectives. Withdrawal from overused drug"/>
 <result pre="of Medicine, Laboratory for Pain Research, University of Antwerp, Wilrijk," exact="Belgium" post="Correspondence: Chiara Demartini (chiara.demartini@mondino.it) The transient receptor potential ankyrin"/>
 <result pre="Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen," exact="Denmark" post="Correspondence: Sabrina Khan (sksabrinakhan@gmail.com) The origin of migraine pain"/>
 <result pre="2040, 3000 CA Rotterdam, The Netherlands; 4Deparment of Pharmacobiology, Cinvestav-Coapa," exact="Mexico" post="City, Mexico Correspondence: Alejandro Labastida-Ramírez (a.labastidaramirez@erasmusmc.nl) Background and aim:"/>
 <result pre="CA Rotterdam, The Netherlands; 4Deparment of Pharmacobiology, Cinvestav-Coapa, Mexico City," exact="Mexico" post="Correspondence: Alejandro Labastida-Ramírez (a.labastidaramirez@erasmusmc.nl) Background and aim: Migraine is"/>
 <result pre="Belgrade, Serbia; 3 Serbian Academy of Sciences and Arts Belgrade," exact="Serbia" post="Correspondence: Ana Lj Podgorac (anasundic@gmail.com) Introduction: Contrary to numerous"/>
 <result pre="3Novartis Global Services Centre, Patient Access Services, Dublin, D04 A9N6," exact="Ireland" post="Correspondence: Leonhard Schaetz (Leonhard.schaetz@novartis.com) Background Migraine is a painful"/>
 <result pre="diseases with high disability, including migraine, across four countries: the" exact="United States" post="of America (USA), Canada, Germany, and the Netherlands. Methods"/>
 <result pre="the USA and government websites for Canada, Germany, and the" exact="Netherlands" post="[4-7]. All the cost estimates were adjusted to year"/>
 <result pre="2016; 316: 2627-46 5. EBIC. Economic Burden of Illness in" exact="Canada" post="online tool 2008. Accessed on 17 May 2018. [Available"/>
 <result pre="6. GBE-BUND. Cost of illness in millions of Euro for" exact="Germany" post="2015. Accessed on 17 May 2018. [Available from: http://www.gbe-bund.de/gbe10/trecherche.prc_them_rech?tk=19200&amp;amp;tk2=19400&amp;amp;p_uid=gast&amp;amp;p_aid=64133544&amp;amp;p_sprache=E&amp;amp;cnt_ut=3&amp;amp;ut=19460"/>
 <result pre="[Available from: http://www.gbe-bund.de/gbe10/trecherche.prc_them_rech?tk=19200&amp;amp;tk2=19400&amp;amp;p_uid=gast&amp;amp;p_aid=64133544&amp;amp;p_sprache=E&amp;amp;cnt_ut=3&amp;amp;ut=19460 7. RIVM. Cost of Illness in the" exact="Netherlands" post="2015. Accessed on 17 May 2018. [Available from: https://statline.rivm.nl/#/RIVM/nl/dataset/50040NED/table?graphtype=Table&amp;amp;ts=1512975518824"/>
 <result pre="with high disability in the USA, Canada, Germany, and the" exact="Netherlands" post="(Comparisons were made for 10 causes of high disability"/>
 <result pre="mellitus; Skin and SC diseases: Skin and subcutaneous diseases; USA:" exact="United States" post="of America; USDs: United States dollars; YLDs: Years lived"/>
 <result pre="Skin and subcutaneous diseases; USA: United States of America; USDs:" exact="United States" post="dollars; YLDs: Years lived with disability. P85 Gender differences"/>
 <result pre="Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen," exact="Denmark" post="Correspondence: Messoud Ashina (ashina@dadlnet.dk) &amp;amp; These authors contributed equally"/>
 <result pre="approved by the Ethics Committee of the Capital Region of" exact="Denmark" post="(H-16014580) and is registered at ClinicalTrials.gov (NCT03481400). All participants"/>
 <result pre="Tirana, Albania; 3Neurology Service, University Hospital Center &quot;Mother Teresa&quot;, Tirana," exact="Albania" post="Correspondence: Jera Kruja (jkruja@gmail.com) Background and Aim: Headache is"/>
 <result pre="University Clinical Center of Ljubljana, Department for vascular Neurology, Ljubljana," exact="Slovenia" post="Correspondence: M Zaletel (mzaletel34@gmail.com) Background: Headache is a common"/>
 <result pre="It can be deleterious for psychological and social well-being. In" exact="Slovenia" post="psychosocial factor for headache are not well established. To"/>
 <result pre="P91 The prevalence and some risk factors chronic headache in" exact="Mongolia" post="Selenge Enkhtuya 1, Otgonbayar Luvsannorov 1, Byambasuren Tsenddorj 2,"/>
 <result pre="aged 18–65 years, living in five geographically different regions of" exact="Mongolia" post="using stratified multistage cluster sampling during the period from"/>
 <result pre="among the population. Conclusion. The prevalence of chronic headache in" exact="Mongolia" post="is high compare to other countries worldwide. These patients"/>
 <result pre="Servicio de Neurología del Hospital Universitario Central de Asturias, Ausurias," exact="Spain" post="Corresponence: M. Castañón (elenaviles90@hotmail.com) BACKGROUND Only two drugs have"/>
 <result pre="P94 Headache education and management in a multi centric study" exact="Cameroon" post="García-Azorín D 1, Kurtis Urra M 2, Molina M"/>
 <result pre="Department, Madrid, Spain; 6Universidad Autónoma de Madrid, Neuroscience Department, Madrid," exact="Spain" post="Correspondence: García-Azorín D (davilink@hotmail.com) Background: Headache is the main"/>
 <result pre="two years attendance to a second level headache centre in" exact="Italy" post="Teresa Catarci, Isabella Falomi and Roberto Batistoni Azienda sanitaria"/>
 <result pre="Program, 2017) and their consulting patients with migraine in the" exact="United States" post="(US) and in five European countries (5-EU: Germany, France,"/>
 <result pre="(US) and in five European countries (5-EU: Germany, France, UK," exact="Italy" post="and Spain). Country‑specific and pooled information was captured for"/>
 <result pre="population consists of the combined populations from Germany, France, UK," exact="Italy" post="and Spain. Abbreviation: MHD migraine headache days. P97 ONAMIG:"/>
 <result pre="Spain; 3Electromyography Unit, Neurophysiology Department, Vall d'Hebron University Hospital, Barcelona," exact="Spain" post="Correspondence: P.Pozo- Rosich (ppozorosich@yahoo.com) Background: Symptoms in migraine could"/>
 <result pre="and Headache Unit. Santa Creu i Sant Pau Hospital, Barcelona," exact="Spain" post="Correspondence: Robert Belvís (rbelvis@santpau.cat) Introduction Only OnabotulinumtoxinA and Topiramate"/>
 <result pre="Department of Clinical Neuroscience, Karolinska Institutet, SE 171 77 Stockholm," exact="Sweden" post="Correspondence: Anna Steinberg (anna.steinberg@sll.se) Background: Cluster headache, a primary"/>
 <result pre="study of all 3240 people aged 16-64 who lived in" exact="Sweden" post="all of 2010 and who at least once during"/>
 <result pre="Results: The prevalence of cluster headache among working-aged people in" exact="Sweden" post="was 0.054%. In 2010, sickness absence rates were 17.30%"/>
 <result pre="(10.89-12.91). A higher rate of cluster headache patients born outside" exact="Sweden" post="were on full-time disability pension; 13.56% (CI 10.85-16.28) compared"/>
 <result pre="was approved by the Regional Ethical Review Board in Stockholm," exact="Sweden" post="P100 Clinical features of pediatric medication overuse headache and"/>
 <result pre="Massimiliano Valeriani Headache Center, Bambino Gesù Children’s Hospital, IRCCS, Rome," exact="Italy" post="Correspondence: Romina Moavero (rominamoavero@hotmail.com) Objectives. To describe the clinical"/>
 <result pre="Psychotherapy and Psychosomatic Medicine, Technische Universität Dresden, Dresden, Sachsen, 01307," exact="Germany" post="Correspodence: Hanna Sophie Lapp (Hanna-Sophie.Lapp@uniklinikum-dresden.de) Background: Migraine is characterized"/>
 <result pre="data were derived from a population based survey conducted in" exact="Estonia" post="form January 2016 till March 2017. The participants were"/>
 <result pre="Department of Neurology, Danish Headache Center, Copenhagen University Hospital, Glostrup," exact="Denmark" post="Correspondence: Mona Ameri Chalmer (mona.ameri.chalmer@regionh.dk) Introduction Omophobia has been"/>
 <result pre="12European Federation of Neurological Associations, Brussels, Belgium; 13Migraine Action, Leicester," exact="United Kingdom;" post="14Migraine Again, USA Correspondence: Audrey Craven (audreycraven@migraine.ie) Introduction As"/>
 <result pre="Funding This study was funded by Novartis Pharma AG, Basel," exact="Switzerland" post="P108 A model concept for assessing the cost-effectiveness of"/>
 <result pre="Funding This study was funded by Novartis Pharma AG, Basel," exact="Switzerland" post="References Vos, T. et al. Global, regional, and national"/>
 <result pre="Bron, France; 5Laboratoire de Génétique moléculaire, Hôpital Lariboisière, 75010 Paris," exact="France" post="Correspondence: Elisa de la Cruz (elisa@sdlc.ca) Background: Migraine aura"/>
 <result pre="AL Guerrero Headache Unit, Neurology Department. Hospital Clínico Universitario, Valladolid," exact="Spain" post="Correspondence: García-Azorín D (davilink@hotmail.com) BACKGROUND: The efficacy and safety"/>
 <result pre="work productivity and activity impairment among patients with migraine in" exact="Germany" post="J. Scott Andrews 1*, Janet Ford 1, Grazia Dell’Agnello"/>
 <result pre="(andrews_jeffrey_scott@lilly.com) Background Limited research exists on patients with migraine in" exact="Germany" post="that addresses both acute and preventive treatment patterns and"/>
 <result pre="effect profile, effective medication, and tolerability. Conclusions Most patients in" exact="Germany" post="are treated with acute medications only, although many experience"/>
 <result pre="9 Department of Neurology, Clínica Universidad de Navarra, Madrid, 28027," exact="Spain" post="Correspondence: Patricia Pozo-Rosich (ppozo@vhebron.net) Background: OnabotulinumtoxinA is an effective,"/>
 <result pre="92612, USA; 5Department of Neurology, University of Duisbury-Essen, Essen, 45122," exact="Germany" post="Correspondence: David W. Dodick (Dodick.David@mayo.edu) Background: The PREEMPT trials"/>
 <result pre="prevalence Female Male F:M ratio Age of onset Race Castillo-1995" exact="Spain" post="S-L 1883 general population 22-73 yr 0.1%GP Li &amp;amp;"/>
 <result pre="638 adult with CDH 21% CDH 10.8% CDH Takase- 2004" exact="Japan" post="ICHD 2 30 NDPH cases of 1760 CDH 1.7%"/>
 <result pre="of 1760 CDH 1.7% CDH 13(43%) 17(57%) 0.8 13-73 Meineri-2004" exact="Italy" post="ICHD2,S-L 18 NDPH cases of 265 CDH 6.7% CDH"/>
 <result pre="tertiary headache center 28% CDH 34(64.2%) 19(35.8%) 1.7 Grande 2009" exact="Norway" post="ICHD 2 30000 general population 30-44 yr 0.03% GP"/>
 <result pre="NDPH 51(72%) 20(28%) 2.5 8-76 Cacausian:80.3% Black:5.6% Hispanic:9.9% Prakash 2012" exact="India" post="M-ICHD2 63 NDPH 36(57%) 27(43%) 1.3 18-68 Rozen 2016"/>
 <result pre="32(33%) 2 Mean: F:32.4 M:35.8 Cacausian:98% Black:1% Hispanic:1% Uniyal 2017" exact="India" post="ICHD-3β 55 NDPH 45.5% 54.5% 0.8 Mean:28.4 S-L Silberstein-Lipton"/>
 <result pre="13(33%) 5(12%) idiopathic intracranial hypertension, high altitude climbing Takase 2004," exact="Japan" post="30 24(80%) - 6(20%) - Robins2010, USA 71 38(53.5%)"/>
 <result pre="HPV vaccination Peng2011, Taiwan 92 65(71%) 3(3%) 24(26%) Parkash2012 ," exact="India" post="63 29(46%) 18(29%) 5(8%) 10(16%) 9(14%) postpartum, medication overuse"/>
 <result pre="7(7%) syncope, hormone, toxin and medication, cervical massage Uniyal 2017," exact="India" post="55 35(63.5%) 10(18%) 5(9.1%) 5(9.1%) Table 5 (abstract P116)."/>
 <result pre="Creu i Sant Pau, Neurology department Hospital Universitario Dexeus. Barcelona," exact="Spain" post="Correspondence: Robert Belvís (rbelvis@santpau.cat) Introduction Typical aura without headache"/>
 <result pre="Italy; 3Institute of Neurology, Catholic University of Sacred Heart, Rome," exact="Italy" post="Correspondence: Giorgia Sforza (sforzagiorgia@gmail.com) BACKGROUND: Primary headache disorders are"/>
 <result pre="Rome, Italy; 2Radiology Unit, Università Campus Bio-Medico di Roma, Rome," exact="Italy" post="Correspondence: C Altamura (c.altamura@unicampus.it) OBJECTIVES: Patients affected by Migraine"/>
 <result pre="University of Rome; 4Center for Sensory-Motor Interaction, alborg University, Aalborg," exact="Denmark" post="Correspondence: Samuela Tarantino (samuela.tarantino@opbg.net) Background A growing body of"/>
 <result pre="Lassenius 3, Timo Purmonen 1 and Markku Nissilä 2 1Novartis" exact="Finland" post="Oy, Espoo, Finland; 2Terveystalo Biobank Finland, Turku, Finland; 3Medaffcon"/>
 <result pre="Espoo, Finland; 2Terveystalo Biobank Finland, Turku, Finland; 3Medaffcon Oy, Espoo," exact="Finland" post="Correspondence: Minna A. Korolainen (Minna.Korolainen@novartis.com) Introduction and objective :"/>
 <result pre="Tarantino, Massimiliano Valeriani Headache Center Bambino Gesù Children Hospital, Rome" exact="Italy" post="Correspondence: Laura Papetti (laura.papetti@opbg.net) Introduction Primary new daily persistent"/>
 <result pre="(the Turkish Headache Database) from four tertiary headache centres in" exact="Turkey" post="was used. This database included headache-defining features according to"/>
 <result pre="Pasic 2 1University Clinical Center Banja Luka, Department of Neurology," exact="Bosnia and Herzegovina;" post="2University Clinical Center Tuzla, Department of Neurology, Bosnia and"/>
 <result pre="Bosnia and Herzegovina; 2University Clinical Center Tuzla, Department of Neurology," exact="Bosnia and Herzegovina;" post="3University Clinical Hospital Mostar, Department of Neurology, Bosnia and"/>
 <result pre="Bosnia and Herzegovina; 3University Clinical Hospital Mostar, Department of Neurology," exact="Bosnia and Herzegovina;" post="4University Clinical Center Sarajevo, Department of Neurology, Bosnia and"/>
 <result pre="Bosnia and Herzegovina; 4University Clinical Center Sarajevo, Department of Neurology," exact="Bosnia and Herzegovina;" post="5Cantonal Hospital &quot;Dr. Safet Mujić&quot; Mostar (Regional Medical Center),"/>
 <result pre="&quot;Dr. Safet Mujić&quot; Mostar (Regional Medical Center), Department of Neurology," exact="Bosnia and Herzegovina" post="Correspondence: Sinisa Miljkovic (sinisa.miljkovic@kc-bl.com) Background: Triptans, ergotamine and dihydroergotamine"/>
 <result pre="from randomized controlled trials. Three health-care systems – of Russia," exact="Spain" post="and Luxemburg – brought different experiences of health service"/>
 <result pre="the greater are the economic savings for society (Luxemburg &amp;gt;" exact="Spain" post="&amp;gt; Russia). Discussion: For the first time, the effectiveness"/>
 <result pre="interventions, and unmet need (published 2007–February 1, 2018; geographical limitation:" exact="United Kingdom," post="France, Germany, Spain, Italy, the Netherlands, Poland, Denmark, Finland,"/>
 <result pre="France, Germany, Spain, Italy, the Netherlands, Poland, Denmark, Finland, Iceland," exact="Norway" post="and Sweden). Searches included: Embase, MEDLINE, and the Cochrane"/>
 <result pre="3Department of Neurosurgery, Rigshospitalet Blegdamsvej, University of Copenhagen, 2100 Copenhagen," exact="Denmark" post="Correspondence: Tone Bruvik Heinskou (tone.bruvik.heinskou@regionh.dk) Background: Prognosis of trigeminal"/>
 <result pre="Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena," exact="Italy" post="Correspondence: Lanfranco Pellesi (lanfranco.pellesi@gmail.com) Background Medication Overuse Headache (MOH)"/>
 <result pre="of Medical and Surgical Sciences, Magna Graecia University of Catanzaro," exact="Italy" post="Correspondence: Laura Rapisarda (laura_rapisarda90@yahoo.it) Objective To evaluate whether high"/>
 <result pre="Hungary; 2Szentágothai János Doctoral School of Neurosciences, Semmelweis University, Budapest," exact="Hungary" post="Correspondence: Ertsey C (konfreg1@bcdtravel.hu) Introduction: Cluster headache (CH), which"/>
 <result pre="Oslo, Nordbyhagen; 6Health Services Research Centre, Akershus University Hospital, Lørenskog," exact="Norway" post="Background : Medication-overuse headache (MOH) is a chronic headache"/>
 <result pre="Italy; 7Administrative Medical Office, ‘San Lazzaro’ Hospital, ASL CN2, Alba," exact="Italy" post="Correspondence: Cinzia Cavestro (cicaves@alice.it); Simona Sacco (simona.sacco@univaq.it) Background. The"/>
 <result pre="(proposed CM-CM). Patients were recruited from tertiary referral clinics in" exact="Denmark" post="and the United States as well as a student"/>
 <result pre="were recruited from tertiary referral clinics in Denmark and the" exact="United States" post="as well as a student population from Russia. All"/>
 <result pre="Basking Ridge, New Jersey, USA; 15Leiden University Center, Leiden, The" exact="Netherlands" post="Correspondence: Hans-Christoph Diener (h.diener@uni-essen.de) Background: Novel preventive migraine therapies"/>
 <result pre="received consultancy fees from Medtronic and research support from the" exact="Netherlands" post="Organisation for Scientific Research (NWO); the European Community; ZonMw;"/>
 <result pre="Inc., Minneapolis, MN, USA; 4Ludwig Maximilian University of Munich, Munich," exact="Germany" post="Correspondence: Charly Gaul (c.gaul@migraene-klinik.de) Background: The randomised controlled PREVA"/>
 <result pre="Epidemiology, Surveillance, and Health Promotion, National Institute of Health, Rome," exact="Italy" post="Correspondence: Antonaci F (fabio.antonaci@unipv.it) Background: Headache is one of"/>
 <result pre="Guerrero Peral AL Headache Unit, Clinico University Hospital. 47005. Valladolid," exact="Spain" post="Correspondence: García-Azorín D (davilink@hotmail.com) INTRODUCTION: Lack of habituation is"/>
 <result pre="Clinical Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven," exact="Belgium" post="Correspondence: Dorien Bamps (dorien.bamps@kuleuven.be) Background: In case of an"/>
 <result pre="from the Ethics Committee of the University Hospitals Gasthuisberg, Leuven," exact="Belgium" post="(S57829) as well as the Federal Agency for Health"/>
 <result pre="the Federal Agency for Health and Medicinal Products (FAHMP) of" exact="Belgium" post="(EudraCT 2014-004736-19). References: [1] Moore RA et al. Overview"/>
 <result pre="Neurosonology Unit, Clinical Neurology, Università Campus Bio-Medico di Roma, Rome," exact="Italy" post="Correspondence: Claudia Altamura (c.altamura@unicampus.it) BACKGROUND Patients with Migraine Aura"/>
 <result pre="Neuro-Ophthalmology Unit, University Hospitals Birmingham NHS Foundation Trust, B15 2TH," exact="United Kingdom" post="(UK); 2Metabolic Neurology, Institute of Metabolism and Systems Research,"/>
 <result pre="Experimental Biomedicine and Clinical Neurosciences (BioNeC), University of Palermo, Palermo," exact="Italy" post="Objective: spontaneous intracranial hypotension (SIH) can sometime represent a"/>
 <result pre="Spain; 2Headache Research Group, Vall d’Hebron Research Institute, Barcelona, 08035," exact="Spain" post="Correspondence: P. Pozo- Rosich (ppozo@vhebron.net) Objective To analyse the"/>
 <result pre="Neurosonology Unit, Neurology Unit, Università Campus Bio-Medico di Roma, Rome," exact="Italy" post="Correspondence: Claudia Altamura (c.altamura@unicampus.it) Introduction Diet has been often"/>
 <result pre="implied in Migraine pathophysiology. [1] Recently the Agricultural Department of" exact="United States" post="published a renewed version of food pyramid: the Healthy"/>
 <result pre="Trieste, Italy; 2Department of Radiology, Cattinara Hospital, University of Trieste," exact="Italy" post="Correspondence: Laura D’Acunto (laura.d.acun@gmail.com) Background: Perfusion computed tomography (PCT)"/>
 <result pre="3Don Carlo Gnocchi Onlus Foundation, Milan, Italy; 4IRCCS-Neuromed, Pozzilli (IS)," exact="Italy" post="Correspondence: Gianluca Coppola (gianluca.coppola@gmail.com) Background Chronic migraine (CM) patients"/>
 <result pre="Medical, Technological and Translational Sciences, Headache Centre, University of Trieste," exact="Italy" post="Correspondence: A. Granato (antonio_granato@hotmail.com) Background Hemicrania continua (HC) is"/>
 <result pre="IDIVAL, Santander, Spain; 2DADO MEDICAL sro, Prague Headache Center, Prague," exact="Czech Republic;" post="3Department of Neurology, Royal Stoke University Hospital, Stoke-on-Trent, UK;"/>
 <result pre="4Amgen Inc., Thousand Oaks, CA, USA; 5Novartis Pharma AG, Basel," exact="Switzerland" post="Presented by Laura Bartolini – Medical Department Novartis Farma,"/>
 <result pre="Switzerland Presented by Laura Bartolini – Medical Department Novartis Farma," exact="Italy" post="Objective: To assess the frequency of injection site reaction-related"/>
 <result pre="Stroke Unit, Osp. Di Circolo - University of Insubria, Varese," exact="Italy" post="Correspondence: L. Princiotta Cariddi (luciapc86@hotmail.it) Background Chronic Migraine (CM)"/>
 <result pre="USA Presented by Annalea Conte – Medical Department Novartis Farma" exact="Italy" post="Objective Report erenumab efficacy in patients with chronic migraine"/>
 <result pre="Pharmaceutical Corporation, East Hanover, NJ, USA; 6Novartis Pharma AG, Basel," exact="Switzerland" post="Presented by Marco Andrè Bassano – Medical Department Novartis"/>
 <result pre="Presented by Marco Andrè Bassano – Medical Department Novartis Farma," exact="Italy" post="Objective: To assess the efficacy and safety of erenumab"/>
 <result pre="Department of Clinical and Experimental Medicine, University of Pisa, Pisa," exact="Italy" post="Correspondence: E. Dini (dini.elisa87@gmail.com) Introduction. The use of Cannabis"/>
 <result pre="Padua, Italy; 3Headache Centre. Hospital SS. Giovanni and Paolo, Venice," exact="Italy" post="Correspondence: Alberto Terrin (alberto.terrin89@gmail.com) Background Migraine with aura (MA)"/>
 <result pre="Medicine and Experimental and Clinical Neurosciences, Physiotherapy, University of Trieste," exact="Italy" post="Correspondence: A. Granato (antonio_granato@hotmail.com) Introduction Efficacy of physical therapy"/>
 <result pre="Massimiliano Valeriani Headache Center, Bambino Gesù Children’s Hospital, IRCCS, Rome," exact="Italy" post="Correspondence: Romina Moavero (rominamoavero@hotmail.com) Objectives. To describe the clinical"/>
 <result pre="Onofri Neuropsychiatric Clinic- Headache Center- San Salvatore Hospital -University L'Aquila" exact="Italy" post="Correspondence: Elisabetta Tozzi (elisabetta.tozzi@univaq.it) Background TheMTHFR variant C677T has"/>
 <result pre="Tozzi Neuropsychiatric Clinic- Headache Center- San Salvatore Hospital -University L'Aquila" exact="Italy" post="Correspondence: Agnese Onofri; Elisabetta Tozzi (elisabetta.tozzi@univaq.it) Background Recently the"/>
 <result pre="Experimental Biomedicine and Clinical Neurosciences (BioNeC), University of Palermo, Palermo," exact="Italy" post="Correspondence: Valerio Giustino (valeriogiustino@msn.com) Background Migraine is a chronic"/>
 <result pre="Department of Neuroscience &quot;Rita Levi Montalcini&quot;, University of Turin ," exact="Italy" post="Correspondence: Milena Zucca, Elisa Rubino (milena.zucca@unito.it) Background: Medication-overuse headache"/>
 <result pre="Rome, Rome, Italy; 4Center for Sensory-Motor Interaction, Aalborg University, Aalborg," exact="Denmark" post="Correspondence: Samuela Tarantino (samuela.tarantino@opbg.net) Background A growing body of"/>
 <result pre="Inferiore; 3Neurology Unit, Maria SS Addolorata Hospital, Eboli, ASL SALERNO," exact="Italy" post="Correspondence: Vincenzo Pizza (vpizza@libero.it) Introduction: headache pathogenesis is complex"/>
 <result pre="4U.O. Hospital Occupational Medicine - IRCCS &quot;S. Maugeri&quot; Foundation, Pavia," exact="Italy" post="Correspondence: Ennio Pucci (ennio.pucci@mondino.it) Introduction: Work and the working"/>
 <result pre="Pain Medicine Unit – University Hospital Policlinico Umberto I, 00161-Rome," exact="Italy" post="Correspondence: M. Puma (martapuma@hotmail.it) Background External nasal pain is"/>
 <result pre="Italy; 3Institute of Neurology, Catholic University of Sacred Heart, Rome," exact="Italy" post="Correspondence: Giorgia Sforza (sforzagiorgia@gmail.com) Background: Primary headache disorders are"/>
 <result pre="hospital &quot;Santa Maria&quot; Terni; 2A.O&quot;S.Maria&quot; Neuroscience and neurorehabilitation Department Terni" exact="Italy" post="Correspondence: Gregorio Iannone (iannonegregorio45@gmail.com) The author reviews the evolution"/>
 <result pre="Florence 50125, Italy; 2Department Neuroscience, University of Florence,Florence 50139 Florence," exact="Italy" post="Correspondence: Maria Nicolodi (info@fondazionesicuterinicolodi.it) Background Allodynia is a feature"/>
 <result pre="3Department of Mathematics and Computer Science, University of Calabria, Rende," exact="Italy" post="Correspondence: Rosario Iannacchero (centrocefaleeaopc@gmail.com) Introduction. Effective resource utilization represents"/>
</results>
